191 related articles for article (PubMed ID: 25137041)
1. Expression of STAT5, COX-2 and PIAS3 in correlation with NSCLC histhopathological features.
Pastuszak-Lewandoska D; Domańska D; Czarnecka KH; Kordiak J; Migdalska-Sęk M; Nawrot E; Kiszałkiewicz J; Antczak A; Górski P; Brzeziańska E
PLoS One; 2014; 9(8):e104265. PubMed ID: 25137041
[TBL] [Abstract][Full Text] [Related]
2. Immunoexpression analysis of selected JAK/STAT pathway molecules in patients with non- small-cell lung cancer.
Pastuszak-Lewandoska D; Domańska-Senderowska D; Kordiak J; Antczak A; Czarnecka KH; Migdalska-Sęk M; Nawrot E; Kiszałkiewicz JM; Brzeziańska-Lasota E
Pol Arch Intern Med; 2017 Nov; 127(11):758-764. PubMed ID: 28972958
[TBL] [Abstract][Full Text] [Related]
3. Protein inhibitor of activated STAT3 expression in lung cancer.
Kluge A; Dabir S; Vlassenbroeck I; Eisenberg R; Dowlati A
Mol Oncol; 2011 Jun; 5(3):256-64. PubMed ID: 21497567
[TBL] [Abstract][Full Text] [Related]
4. Cooperative interaction between protein inhibitor of activated signal transducer and activator of transcription-3 with epidermal growth factor receptor blockade in lung cancer.
Kluge A; Dabir S; Kern J; Nethery D; Halmos B; Ma P; Dowlati A
Int J Cancer; 2009 Oct; 125(7):1728-34. PubMed ID: 19569236
[TBL] [Abstract][Full Text] [Related]
5. PAI-1/PIAS3/Stat3/miR-34a forms a positive feedback loop to promote EMT-mediated metastasis through Stat3 signaling in Non-small cell lung cancer.
Lin X; Lin BW; Chen XL; Zhang BL; Xiao XJ; Shi JS; Lin JD; Chen X
Biochem Biophys Res Commun; 2017 Dec; 493(4):1464-1470. PubMed ID: 28988111
[TBL] [Abstract][Full Text] [Related]
6. N-terminal truncation of Stat5a/b circumvents PIAS3-mediated transcriptional inhibition of Stat5 in prostate cancer cells.
Dagvadorj A; Tan SH; Liao Z; Xie J; Nurmi M; Alanen K; Rui H; Mirtti T; Nevalainen MT
Int J Biochem Cell Biol; 2010 Dec; 42(12):2037-46. PubMed ID: 20854925
[TBL] [Abstract][Full Text] [Related]
7. PIAS3 expression in squamous cell lung cancer is low and predicts overall survival.
Abbas R; McColl KS; Kresak A; Yang M; Chen Y; Fu P; Wildey G; Dowlati A
Cancer Med; 2015 Mar; 4(3):325-32. PubMed ID: 25573684
[TBL] [Abstract][Full Text] [Related]
8. The Expression Levels of IL-4/IL-13/STAT6 Signaling Pathway Genes and SOCS3 Could Help to Differentiate the Histopathological Subtypes of Non-Small Cell Lung Carcinoma.
Pastuszak-Lewandoska D; Domańska-Senderowska D; Antczak A; Kordiak J; Górski P; Czarnecka KH; Migdalska-Sęk M; Nawrot E; Kiszałkiewicz JM; Brzeziańska-Lasota E
Mol Diagn Ther; 2018 Oct; 22(5):621-629. PubMed ID: 30105735
[TBL] [Abstract][Full Text] [Related]
9. STAT5A and STAT5B have opposite correlations with drug response gene expression.
Lamba V; Jia B; Liang F
Biochem Biophys Res Commun; 2016 Oct; 479(2):117-124. PubMed ID: 27264955
[TBL] [Abstract][Full Text] [Related]
10. Low PIAS3 expression in malignant mesothelioma is associated with increased STAT3 activation and poor patient survival.
Dabir S; Kluge A; Kresak A; Yang M; Fu P; Groner B; Wildey G; Dowlati A
Clin Cancer Res; 2014 Oct; 20(19):5124-32. PubMed ID: 25124686
[TBL] [Abstract][Full Text] [Related]
11. STAT5 isoforms regulate colorectal cancer cell apoptosis via reduction of mitochondrial membrane potential and generation of reactive oxygen species.
Du W; Wang YC; Hong J; Su WY; Lin YW; Lu R; Xiong H; Fang JY
J Cell Physiol; 2012 Jun; 227(6):2421-9. PubMed ID: 21826656
[TBL] [Abstract][Full Text] [Related]
12. The association and nuclear translocation of the PIAS3-STAT3 complex is ligand and time dependent.
Dabir S; Kluge A; Dowlati A
Mol Cancer Res; 2009 Nov; 7(11):1854-60. PubMed ID: 19903771
[TBL] [Abstract][Full Text] [Related]
13. [Expression of PIAS3 an inhibitor of activated STAT3 protein in human prostate cancer].
Gan L; Yin ZF; Li M
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(6):419-21. PubMed ID: 18581899
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-18a modulates STAT3 activity through negative regulation of PIAS3 during gastric adenocarcinogenesis.
Wu W; Takanashi M; Borjigin N; Ohno SI; Fujita K; Hoshino S; Osaka Y; Tsuchida A; Kuroda M
Br J Cancer; 2013 Feb; 108(3):653-61. PubMed ID: 23322197
[TBL] [Abstract][Full Text] [Related]
15. COX-2 overexpression and -8473 T/C polymorphism in 3' UTR in non-small cell lung cancer.
Bhat IA; Rasool R; Qasim I; Masoodi KZ; Paul SA; Bhat BA; Ganaie FA; Aziz SA; Shah ZA
Tumour Biol; 2014 Nov; 35(11):11209-18. PubMed ID: 25113252
[TBL] [Abstract][Full Text] [Related]
16. The intracellular delivery of a recombinant peptide derived from the acidic domain of PIAS3 inhibits STAT3 transactivation and induces tumor cell death.
Borghouts C; Tittmann H; Delis N; Kirchenbauer M; Brill B; Groner B
Mol Cancer Res; 2010 Apr; 8(4):539-53. PubMed ID: 20371673
[TBL] [Abstract][Full Text] [Related]
17. PIAS3-mediated feedback loops promote chronic colitis-associated malignant transformation.
Ma J; Yang Y; Fu Y; Guo F; Zhang X; Xiao S; Zhu W; Huang Z; Zhang J; Chen J
Theranostics; 2018; 8(11):3022-3037. PubMed ID: 29896300
[No Abstract] [Full Text] [Related]
18. [Mechanisms of EGF regulation of COX-2 through the STAT5 signaling pathway in human lung adenocarcinoma A549 cells].
Cao S; Zhao G; Dong Q; Han J; Xin Y; Yan Y; Li J; Cui J
Zhongguo Fei Ai Za Zhi; 2013 Apr; 16(4):169-76. PubMed ID: 23601296
[TBL] [Abstract][Full Text] [Related]
19. RARβ Promoter Methylation as an Epigenetic Mechanism of Gene Silencing in Non-small Cell Lung Cancer.
Dutkowska A; Antczak A; Pastuszak-Lewandoska D; Migdalska-Sek M; Czarnecka KH; Górski P; Kordiak J; Nawrot E; Brzeziańska-Lasota E
Adv Exp Med Biol; 2016; 878():29-38. PubMed ID: 26453065
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of lysyl oxidase-like 2 (LOXL2) is associated with disease progression in lung adenocarcinomas.
Zhan P; Shen XK; Qian Q; Zhu JP; Zhang Y; Xie HY; Xu CH; Hao KK; Hu W; Xia N; Lu GJ; Yu LK
Med Oncol; 2012 Jun; 29(2):648-55. PubMed ID: 21519871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]